GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » ROE % Adjusted to Book Value

Orient Europharma Co (ROCO:4120) ROE % Adjusted to Book Value : -12.83% (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co ROE % Adjusted to Book Value?

Orient Europharma Co's ROE % for the quarter that ended in Dec. 2024 was -10.39%. Orient Europharma Co's PB Ratio for the quarter that ended in Dec. 2024 was 0.81. Orient Europharma Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -12.83%.


Orient Europharma Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Orient Europharma Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co ROE % Adjusted to Book Value Chart

Orient Europharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.79 3.65 -9.90 4.66 -8.07

Orient Europharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.18 -9.89 -8.21 1.02 -12.83

Competitive Comparison of Orient Europharma Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Europharma Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orient Europharma Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Europharma Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Orient Europharma Co's ROE % Adjusted to Book Value falls into.



Orient Europharma Co ROE % Adjusted to Book Value Calculation

Orient Europharma Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.54% / 0.81
=-8.07%

Orient Europharma Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-10.39% / 0.81
=-12.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Europharma Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Europharma Co Business Description

Traded in Other Exchanges
N/A
Address
13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines